WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s stock price fell 1.1% during trading on Wednesday . The company traded as low as $15.38 and last traded at $15.40. 2,627 shares were traded during mid-day trading, The stock had previously closed at $15.58.
WisdomTree BioRevolution Fund Stock Performance
The firm has a market cap of $2.31 million, a P/E ratio of 16.52 and a beta of 1.18. The business’s 50-day simple moving average is $16.84 and its 200 day simple moving average is $15.93.
Institutional Investors Weigh In On WisdomTree BioRevolution Fund
An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Flow Traders U.S. LLC grew its holdings in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 15.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 93,700 shares of the company’s stock after acquiring an additional 12,679 shares during the period. Flow Traders U.S. LLC’s holdings in WisdomTree BioRevolution Fund were worth $1,627,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Further Reading
- Five stocks we like better than WisdomTree BioRevolution Fund
- What Does Downgrade Mean in Investing?
- United Airlines Soars on Earnings Beat
- Investing in Travel Stocks Benefits
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.